These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1674408)
21. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities. Siporin C Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364 [TBL] [Abstract][Full Text] [Related]
22. [Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology]. Matsuda S; Shimizu T; Cho N; Okada H Jpn J Antibiot; 1993 Jun; 46(6):492-504. PubMed ID: 8395608 [TBL] [Abstract][Full Text] [Related]
23. [Chinolone--the survey remembered]. Heinzl S Med Monatsschr Pharm; 1998 Aug; 21(8):229. PubMed ID: 9729673 [No Abstract] [Full Text] [Related]
24. [New quinolones: similarities and differences]. Levi GC AMB Rev Assoc Med Bras; 1989; 35(5):202-6. PubMed ID: 2486418 [TBL] [Abstract][Full Text] [Related]
25. The quinolones and renal infection. Ronald A Drugs; 1999; 58 Suppl 2():96-8. PubMed ID: 10553715 [TBL] [Abstract][Full Text] [Related]
26. The role of the fluoroquinolones in primary care practice. Harding GK Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484 [No Abstract] [Full Text] [Related]
27. [Drug positioning of parenteral fluoroquinolones in management of infectious diseases. Discussion]. Kobayashi H; Aikawa N; Saito A; Shuden S; Minami S Jpn J Antibiot; 2002 Aug; 55(4):345-60. PubMed ID: 12378867 [No Abstract] [Full Text] [Related]
30. The place of quinolones in bacterial infections. Neu HC Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577 [TBL] [Abstract][Full Text] [Related]
31. New oral and parenteral quinolones. A summary. Neu HC Am J Med; 1989 Nov; 87(5A):283S-287S. PubMed ID: 2589378 [No Abstract] [Full Text] [Related]
32. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections. Ball P Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483 [No Abstract] [Full Text] [Related]
33. [Should the use of gyrase inhibitors be limited to hospitals?]. Shah PM Immun Infekt; 1990 Jun; 18(3):69-70. PubMed ID: 2165996 [No Abstract] [Full Text] [Related]
34. [New antibacterial agents]. Järvinen A; Valtonen V Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883 [No Abstract] [Full Text] [Related]
35. [The new quinolones]. Lontie M J Pharm Belg; 1989; 44(4):292-301. PubMed ID: 2691640 [TBL] [Abstract][Full Text] [Related]
36. [Enrofloxacin, a new drug for ornamental fish]. Reimlinger M; Hoffmann R; Pfeil-Putzien C; Scheinert P Tierarztl Prax; 1990 Dec; 18(6):653-7. PubMed ID: 2080513 [TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates. Matsumoto T; Tateda K; Ishii Y; Ohno A; Miyazaki S; Yamaguchi K Drugs; 1995; 49 Suppl 2():219-21. PubMed ID: 8549309 [No Abstract] [Full Text] [Related]
38. [Quinolones: new synthetic antimicrobial agents]. Lopes HV AMB Rev Assoc Med Bras; 1988; 34(2):54-60. PubMed ID: 3072599 [No Abstract] [Full Text] [Related]
39. [Quinolones]. Lode H Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290 [TBL] [Abstract][Full Text] [Related]
40. [Clinical studies of miloxacin for acute intestinitis (author's transl)]. Nakano M; Kanzaki R; Hayakawa M; Adachi M; Kawai M; Imadaka K; Takizuka H; Okayama K; Katsu M; Nose N; Notoya T; Takeda N Kansenshogaku Zasshi; 1981 Nov; 55(11):819-25. PubMed ID: 6801153 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]